BACKGROUND. Amitriptyline reduces the pain caused by peripheral-nerve disease, but treatment is often limited by side effects related to the drug's many pharmacologic actions. Selective agents might be safer and more effective. METHODS. We carried out two randomized, double-blind, crossover studies in patients with painful diabetic neuropathy, comparing amitriptyline with the relatively selective blocker of norepinephrine reuptake desipramine in 38 patients, and comparing the selective blocker of serotonin reuptake fluoxetine with placebo in 46 patients. Fifty-seven patients were randomly assigned to a study as well as to the order of treatment, permitting comparison among all three drugs and placebo as the first treatment. The patients rated the degree of pain present each day using verbal descriptors, and they also assessed the extent of pain relief globally at the end of each treatment period. RESULTS. After individual dose titration, the mean daily doses of the drugs were as follows: amitriptyline, 105 mg; desipramine, 111 mg; and fluoxetine, 40 mg. There was moderate or greater relief of pain in 28 of the 38 patients (74 percent) who received amitriptyline, 23 of the 38 patients (61 percent) who received desipramine, 22 of the 46 patients (48 percent) who received fluoxetine, and 19 of the 46 patients (41 percent) who received placebo. The differences in responses between amitriptyline and desipramine and between fluoxetine and placebo were not statistically significant, but both amitriptyline and desipramine were superior to placebo. Amitriptyline and desipramine were as effective in patients who were not depressed as in depressed patients, but fluoxetine was effective only in depressed patients. CONCLUSIONS. Desipramine relieves pain caused by diabetic neuropathy with efficacy similar to that of amitriptyline, offering an alternative for patients unable to tolerate the latter. Blockade of norepinephrine reuptake is likely to mediate the analgesic effect of these antidepressant drugs in diabetic neuropathy. Fluoxetine, which blocks serotonin uptake, is no more effective than placebo for the relief of pain.
Source Information
Neurobiology and Anesthesiology Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, MD 20892.
This article has been cited by other articles:
Rutkove, S. B.
(2009). A 52-Year-Old Woman With Disabling Peripheral Neuropathy: Review of Diabetic Polyneuropathy. JAMA
302: 1451-1458
[Abstract][Full Text]
Rogers, M., Rasheed, A., Moradimehr, A., Baumrucker, S. J.
(2009). Memantine (Namenda) for Neuropathic Pain. AM J HOSP PALLIAT CARE
26: 57-59
[Abstract]
MEASE, P. J., CLAUW, D. J., GENDREAU, R. M., RAO, S. G., KRANZLER, J., CHEN, W., PALMER, R. H.
(2009). The Efficacy and Safety of Milnacipran for Treatment of Fibromyalgia. A Randomized, Double-blind, Placebo-controlled Trial. The Journal of Rheumatology
36: 398-409
[Abstract][Full Text]
Scrivani, S. J., Keith, D. A., Kaban, L. B.
(2008). Temporomandibular Disorders. NEJM
359: 2693-2705
[Full Text]
Suzuki, T., Ueta, K., Tamagaki, S., Mashimo, T.
(2008). Antiallodynic and Antihyperalgesic Effect of Milnacipran in Mice with Spinal Nerve Ligation. Anesth. Analg.
106: 1309-1315
[Abstract][Full Text]
Tzschentke, T. M., Christoph, T., Kogel, B., Schiene, K., Hennies, H.-H., Englberger, W., Haurand, M., Jahnel, U., Cremers, T. I. F. H., Friderichs, E., De Vry, J.
(2007). ( )-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol Hydrochloride (Tapentadol HCl): a Novel {micro}-Opioid Receptor Agonist/Norepinephrine Reuptake Inhibitor with Broad-Spectrum Analgesic Properties. J. Pharmacol. Exp. Ther.
323: 265-276
[Abstract][Full Text]
Smith, R. G.
(2007). Painful Diabetic Peripheral Neuropathy. J. Am. Podiatr. Med. Assoc.
97: 394-401
[Abstract][Full Text]
Zhao, Z.-Q., Chiechio, S., Sun, Y.-G., Zhang, K.-H., Zhao, C.-S., Scott, M., Johnson, R. L., Deneris, E. S., Renner, K. J., Gereau, R. W. IV, Chen, Z.-F.
(2007). Mice Lacking Central Serotonergic Neurons Show Enhanced Inflammatory Pain and an Impaired Analgesic Response to Antidepressant Drugs. J. Neurosci.
27: 6045-6053
[Abstract][Full Text]
Huizinga, M. M., Peltier, A.
(2007). Painful Diabetic Neuropathy: A Management-Centered Review. Clin. Diabetes
25: 6-15
[Abstract][Full Text]
Foster, T. S.
(2007). Efficacy and Safety of {alpha}-Lipoic Acid Supplementation in the Treatment of Symptomatic Diabetic Neuropathy. The Diabetes Educator
33: 111-117
[Abstract][Full Text]
Wernicke, J. F., Pritchett, Y. L., D'Souza, D. N., Waninger, A., Tran, P., Iyengar, S., Raskin, J.
(2006). A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology
67: 1411-1420
[Abstract][Full Text]
Sharp, J., Keefe, B.
(2006). Psychiatry in Chronic Pain: A Review and Update. Focus
4: 573-
[Full Text]
Jensen, T. S, Backonja, M.-M., Jimenez, S. H., Tesfaye, S., Valensi, P., Ziegler, D.
(2006). New perspectives on the management of diabetic peripheral neuropathic pain. Diabetes and Vascular Disease Research
3: 108-119
[Abstract]
Gilron, I., Watson, C. P. N., Cahill, C. M., Moulin, D. E.
(2006). Neuropathic pain: a practical guide for the clinician.. CMAJ
175: 265-275
[Abstract][Full Text]
Argoff, C. E., Backonja, M.-M., Belgrade, M. J., Bennett, G. J., Clark, M. R., Cole, B. E., Fishbain, D. A., Irving, G. A., McCarberg, B. H., McLean, M. J.
(2006). Consensus Guidelines: Treatment Planning and Options. Mayo Clin Proc.
81: S12-S25
[Abstract][Full Text]
Belgrade, M. J., Cole, B. E., McCarberg, B. H., McLean, M. J.
(2006). Diabetic Peripheral Neuropathic Pain: Case Studies. Mayo Clin Proc.
81: S26-S32
[Abstract][Full Text]
Rathur, H. M., Boulton, A. J. M.
(2005). Recent advances in the diagnosis and management of diabetic neuropathy. J Bone Joint Surg Br
87-B: 1605-1610
[Full Text]
Suzuki, T., Li, Y. H., Mashimo, T.
(2005). The Antiallodynic and Antihyperalgesic Effects of Neurotropin(R) in Mice with Spinal Nerve Ligation. Anesth. Analg.
101: 793-799
[Abstract][Full Text]
Corbett, C. F.
(2005). Practical Management of Patients With Painful Diabetic Neuropathy. The Diabetes Educator
31: 523-540
[Abstract][Full Text]
Scott, K., Kothari, M. J.
(2005). Evaluating the Patient with Peripheral Nervous System Complaints. JAOA: Journal of the American Osteopathic Association
105: 71-83
[Abstract][Full Text]
Jones, C. K., Peters, S. C., Shannon, H. E.
(2005). Efficacy of Duloxetine, a Potent and Balanced Serotonergic and Noradrenergic Reuptake Inhibitor, in Inflammatory and Acute Pain Models in Rodents. J. Pharmacol. Exp. Ther.
312: 726-732
[Abstract][Full Text]
Chen, H., Lamer, T. J., Rho, R. H., Marshall, K. A., Sitzman, B. T., Ghazi, S. M., Brewer, R. P.
(2004). Contemporary Management of Neuropathic Pain for the Primary Care Physician. Mayo Clin Proc.
79: 1533-1545
[Abstract]
Iyengar, S., Webster, A. A., Hemrick-Luecke, S. K., Xu, J. Y., Simmons, R. M. A.
(2004). Efficacy of Duloxetine, a Potent and Balanced Serotonin-Norepinephrine Reuptake Inhibitor in Persistent Pain Models in Rats. J. Pharmacol. Exp. Ther.
311: 576-584
[Abstract][Full Text]
Phillips, W. J., Currier, B. L.
(2004). Analgesic Pharmacology: II. Specific Analgesics. J Am Acad Orthop Surg
12: 221-233
[Abstract][Full Text]
Boulton, A. J.M., Malik, R. A., Arezzo, J. C., Sosenko, J. M.
(2004). Diabetic Somatic Neuropathies. Diabetes Care
27: 1458-1486
[Full Text]
Amato, A. A., Oaklander, A. L.
(2004). Case 16-2004 - A 76-Year-Old Woman with Numbness and Pain in the Feet and Legs. NEJM
350: 2181-2189
[Full Text]
Gray, S. L, Hedrick, S. C, Rhinard, E. E, Sales, A. E, Sullivan, J. H, Tornatore, J. B, Curtis, M. P
(2003). Potentially Inappropriate Medication Use in Community Residential Care Facilities. The Annals of Pharmacotherapy
37: 988-993
[Abstract][Full Text]
Srinivasa, V., Gerner, P., Haderer, A., Abdi, S., Jarolim, P., Wang, G. K.
(2003). The Relative Toxicity of Amitriptyline, Bupivacaine, and Levobupivacaine Administered as Rapid Infusions in Rats. Anesth. Analg.
97: 91-95
[Abstract][Full Text]
Sindrup, S. H., Bach, F. W., Madsen, C., Gram, L. F., Jensen, T. S.
(2003). Venlafaxine versus imipramine in painful polyneuropathy: A randomized, controlled trial. Neurology
60: 1284-1289
[Abstract][Full Text]
Rowbotham, M. C., Twilling, L., Davies, P. S., Reisner, L., Taylor, K., Mohr, D.
(2003). Oral Opioid Therapy for Chronic Peripheral and Central Neuropathic Pain. NEJM
348: 1223-1232
[Abstract][Full Text]
Mendell, J. R., Sahenk, Z.
(2003). Painful Sensory Neuropathy. NEJM
348: 1243-1255
[Full Text]
Gimbel, J. S., Richards, P., Portenoy, R. K.
(2003). Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial. Neurology
60: 927-934
[Abstract][Full Text]
Leo, R. J., Pristach, C. A., Streltzer, J.
(2003). Incorporating Pain Management Training Into the Psychiatry Residency Curriculum. Acad. Psychiatry
27: 1-11
[Abstract][Full Text]
Tack, C. J., van Gurp, P. J., Holmes, C., Goldstein, D. S.
(2002). Local Sympathetic Denervation in Painful Diabetic Neuropathy. Diabetes
51: 3545-3553
[Abstract][Full Text]
Ziemann, U., Wittenberg, G. F., Cohen, L. G.
(2002). Stimulation-Induced Within-Representation and Across-Representation Plasticity in Human Motor Cortex. J. Neurosci.
22: 5563-5571
[Abstract][Full Text]
Spiller, R
(2002). Pharmacotherapy: non-serotonergic mechanisms. Gut
51: i87-90
[Abstract][Full Text]
Ly, K. L., Chidgey, J., Addington-Hall, J., Hotopf, M.
(2002). Depression in palliative care: a systematic review. Part 2. Treatment. Palliat Med
16: 279-284
[Abstract]
Nathan, D. M.
(2002). The Impact of Clinical Trials on the Treatment of Diabetes Mellitus. J. Clin. Endocrinol. Metab.
87: 1929-1937
[Abstract][Full Text]
CARRINGTON, J., GETTER, L., BROWN, R. S.
(2001). Diabetic neuropathy masquerading as glossodynia. Journal of the American Dental Association
132: 1549-1551
[Abstract][Full Text]
Chodosh, J., Ferrell, B. A., Shekelle, P. G., Wenger, N. S.
(2001). Quality Indicators for Pain Management in Vulnerable Elders. ANN INTERN MED
135: 731-735
[Full Text]
Harden, R. N.
(2001). Complex regional pain syndrome. Br J Anaesth
87: 99-106
[Abstract][Full Text]
Sindrup, S. H., Jensen, T. S.
(2000). Pharmacologic treatment of pain in polyneuropathy. Neurology
55: 915-920
[Abstract][Full Text]
Gilron, I., Booher, S. L., Rowan, J. S., Smoller, B., Max, M. B.
(2000). A randomized, controlled trial of high-dose dextromethorphan in facial neuralgias. Neurology
55: 964-971
[Abstract][Full Text]
Fudin, J., Audette, C. M., Morello, C. M., Leckband, S. G., Stoner, C. P., Moorhouse, D. F., Sahagian, G. A.
(2000). Gabapentin vs Amitriptyline for the Treatment of Peripheral Neuropathy. Arch Intern Med
160: 1040-1041
[Full Text]
McArthur, J. C., Yiannoutsos, C., Simpson, D. M., Adornato, B. T., Singer, E. J., Hollander, H., Marra, C., Rubin, M., Cohen, B. A., Tucker, T., Navia, B. A., Schifitto, G., Katzenstein, D., Rask, C., Zaborski, L., Smith, M. E., Shriver, S., Millar, L., Clifford, D. B.
(2000). A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. Neurology
54: 1080-1088
[Abstract][Full Text]
Morello, C. M., Leckband, S. G., Stoner, C. P., Moorhouse, D. F., Sahagian, G. A.
(1999). Randomized Double-blind Study Comparing the Efficacy of Gabapentin With Amitriptyline on Diabetic Peripheral Neuropathy Pain. Arch Intern Med
159: 1931-1937
[Abstract][Full Text]
Jain, S., Datta, S., Tundis, D.
(1999). Management of Chronic Postthoracotomy Pain. SEMIN CARDIOTHORAC VASC ANESTH
3: 191-203
[Abstract]
Kaptchuk, T. J., Ulett, G. A., King, S. A., Shlay, J. C., Cohn, D. L., Chaloner, K., Max, M. B., Reichelderfer, P., Flaws, B., Wentworth, D., Hillman, S., Brizz, B.
(1999). Acupuncture and Amitriptyline for HIV-Related Peripheral Neuropathic Pain. JAMA
281: 1270-1272
[Full Text]
Backonja, M., Beydoun, A., Edwards, K. R., Schwartz, S. L., Fonseca, V., Hes, M., LaMoreaux, L., Garofalo, E., for the Gabapentin Diabetic Neuropathy Study Group,
(1998). Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: A Randomized Controlled Trial. JAMA
280: 1831-1836
[Abstract][Full Text]
Low, P. A., Dotson, R. M.
(1998). Symptomatic Treatment of Painful Neuropathy. JAMA
280: 1863-1864
[Full Text]
Shlay, J. C., Chaloner, K., Max, M. B., Flaws, B., Reichelderfer, P., Wentworth, D., Hillman, S., Brizz, B., Cohn, D. L., for the Terry Beirn Community Programs for Clinica,
(1998). Acupuncture and Amitriptyline for Pain Due to HIV-Related Peripheral Neuropathy: A Randomized Controlled Trial. JAMA
280: 1590-1595
[Abstract][Full Text]
Gorelick, A. B., Koshy, S. S., Hooper, F. G., Bennett, T. C., Chey, W. D., Hasler, W. L.
(1998). Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans. Am. J. Physiol. Gastrointest. Liver Physiol.
275: G460-G466
[Abstract][Full Text]
Peghini, P L, Katz, P O, Castell, D O
(1998). Imipramine decreases oesophageal pain perception in human male volunteers. Gut
42: 807-813
[Abstract][Full Text]
Hoss, D., Segal, S.
(1998). Scalp Dysesthesia. Arch Dermatol
134: 327-330
[Abstract][Full Text]
Pancrazio, J. J., Kamatchi, G. L., Roscoe, A. K., Lynch III, C.
(1998). Inhibition of Neuronal Na+ Channels by Antidepressant Drugs. J. Pharmacol. Exp. Ther.
284: 208-214
[Abstract][Full Text]
Smith, A. J.
(1998). The analgesic effects of selective serotonin reuptake inhibitors. J Psychopharmacol
12: 407-413
[Abstract]
McQuay, H. J, Moore, R A.
(1997). Antidepressants and chronic pain. BMJ
314: 763-763
[Full Text]
Dubner, R.
(1997). Three Decades of Pain Research and its Control. JDR
76: 730-733
Levy, M. H.
(1996). Pharmacologic Treatment of Cancer Pain. NEJM
335: 1124-1132
[Full Text]
Godfrey, R. G.
(1996). A Guide to the Understanding and Use of Tricyclic Antidepressants in the Overall Management of Fibromyalgia and Other Chronic Pain Syndromes. Arch Intern Med
156: 1047-1052
[Abstract]
Garfin, S. R.
(1995). A 50-Year-Old Woman With Disabling Spinal Stenosis. JAMA
274: 1949-1954
[Abstract]
Mahoney, J. E., Gray, S. L., Carnes, M., Klein, M.
(1995). Prevention and Treatment of the Complications of Diabetes Mellitus. NEJM
333: 802-802
[Full Text]
Clark, C. M., Lee, D. A.
(1995). Prevention and Treatment of the Complications of Diabetes Mellitus. NEJM
332: 1210-1217
[Full Text]
Himmelstein, D. U., Woolhandler, S.
(1995). Inappropriate Drug Prescribing-Reply. JAMA
273: 457-458
[Abstract]
Gram, L. F.
(1994). Fluoxetine. NEJM
331: 1354-1361
[Full Text]
Hare, D. L., Venes, D. J., Cannon, R. O.
(1994). Imipramine in Patients with Chest Pain Despite Normal Coronary Angiograms. NEJM
331: 882-883
[Full Text]
Cannon, R. O., Quyyumi, A. A., Mincemoyer, R., Stine, A. M., Gracely, R. H., Smith, W. B., Geraci, M. F., Black, B. C., Uhde, T. W., Waclawiw, M. A., Maher, K., Benjamin, S. B.
(1994). Imipramine in Patients with Chest Pain Despite Normal Coronary Angiograms. NEJM
330: 1411-1417
[Abstract][Full Text]
Sullivan, M., Katon, W., Russo, J., Dobie, R., Sakai, C.
(1993). A Randomized Trial of Nortriptyline for Severe Chronic Tinnitus: Effects on Depression, Disability, and Tinnitus Symptoms. Arch Intern Med
153: 2251-2259
[Abstract]
Nathan, D. M.
(1993). Long-Term Complications of Diabetes Mellitus. NEJM
328: 1676-1685
[Full Text]
(1992). AMITRIPTYLINE AND DESIPRAMINE RELIEVE PAIN IN DIABETIC NEUROPATHY. JWatch General
1992: 5-5
[Full Text]
Previous
